Drug Discovery

Will unlocking the secrets of the microbiome yield a promising new horizon for medicine?

Industry experts share how their therapeutic products are shaping the future of the pharmaceutical landscape.

Some have dismissed excitement about the microbiome as “hype,” but real results are beginning to be seen.

David Donabedian of Axial Biotherapuetics explains the role of the microbiome in the onset of Parkinson's Disease and autism.

It's time to rewrite the narrative about Africa's role in the pharmaceutical industry.

Oncology research has come a long way over the past 30 years, but we must transform outdated practices to further improve drug discovery innovation.

How is the changing landscape of microbiome R&D shaping conversations with regulators?

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

Innovation in the ENT space is lacking. Lyra Therapeutics is, therefore, trying to create solutions for patient with unmet clinical needs.

Sitting Down With… Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.